Jesse J. Jung
About
In The Last Decade
Jesse J. Jung
64 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 66
- Ophthalmology 1.5k
- Radiology, Nuclear Medicine and Imaging 947
- Molecular Biology 169
- Epidemiology 103
- Neurology 71
Countries citing papers authored by Jesse J. Jung
This map shows the geographic impact of Jesse J. Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse J. Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse J. Jung more than expected).
Fields of papers citing papers by Jesse J. Jung
This network shows the impact of papers produced by Jesse J. Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse J. Jung. The network helps show where Jesse J. Jung may publish in the future.
Co-authorship network of co-authors of Jesse J. Jung
This figure shows the co-authorship network connecting the top 25 collaborators of Jesse J. Jung. A scholar is included among the top collaborators of Jesse J. Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse J. Jung. Jesse J. Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | The effect of astigmatism on vessel density measurements derived from optical coherence tomography Angiography (OCTA) | 1 |
| 4 | 15 | |
| 5 | 14 | |
| 6 | Segmentation and characterization of intra-retina layer thickness in widefield SS-OCT: comparison of normal retina and diabetic retinopathy with/without macular edema | 1 |
| 7 | 6 | |
| 8 | 32 | |
| 9 | 123 | |
| 10 | 35 | |
| 11 | 61 | |
| 12 | Origin and behavior of Type 3 neovascularization revealed by spectral-domain optical coherence tomography | 3 |
| 13 | Central Serous Chorioretinopathy Treated with Mineralocorticoid Antagonists: a Retrospective Study Analyzing the Clinical and Multimodal Imaging Response to Therapy | 1 |
| 14 | 15 | |
| 15 | Retinal Pigment Epithelium Atrophy in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration | 2 |
| 16 | The Incidence of Neovascular Subtypes in Newly Diagnosed Wet Age-Related Macular Degeneration | 2 |
| 17 | 9 | |
| 18 | 5 | |
| 19 | 4 | |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.